nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Gastrointestinal pain—Vismodegib—skin cancer	0.0063	0.00635	CcSEcCtD
Labetalol—Dry eye—Temozolomide—skin cancer	0.0063	0.00635	CcSEcCtD
Labetalol—Throat sore—Docetaxel—skin cancer	0.00629	0.00634	CcSEcCtD
Labetalol—Oropharyngeal discomfort—Docetaxel—skin cancer	0.00624	0.00629	CcSEcCtD
Labetalol—Abdominal pain—Vismodegib—skin cancer	0.00609	0.00614	CcSEcCtD
Labetalol—Alopecia—Vemurafenib—skin cancer	0.00592	0.00597	CcSEcCtD
Labetalol—Erythema—Vemurafenib—skin cancer	0.00584	0.00588	CcSEcCtD
Labetalol—Lethargy—Dactinomycin—skin cancer	0.00559	0.00563	CcSEcCtD
Labetalol—Asthenia—Vismodegib—skin cancer	0.00553	0.00557	CcSEcCtD
Labetalol—Visual impairment—Imiquimod—skin cancer	0.00551	0.00555	CcSEcCtD
Labetalol—Pruritus—Vismodegib—skin cancer	0.00545	0.0055	CcSEcCtD
Labetalol—Nasal congestion—Temozolomide—skin cancer	0.00544	0.00548	CcSEcCtD
Labetalol—Flushing—Imiquimod—skin cancer	0.00531	0.00535	CcSEcCtD
Labetalol—Diarrhoea—Vismodegib—skin cancer	0.00527	0.00531	CcSEcCtD
Labetalol—Amnesia—Temozolomide—skin cancer	0.00527	0.00531	CcSEcCtD
Labetalol—Disorientation—Fluorouracil—skin cancer	0.0051	0.00514	CcSEcCtD
Labetalol—Liver function test abnormal—Dactinomycin—skin cancer	0.00505	0.00509	CcSEcCtD
Labetalol—Alopecia—Imiquimod—skin cancer	0.00505	0.00509	CcSEcCtD
Labetalol—Mental disorder—Imiquimod—skin cancer	0.00501	0.00505	CcSEcCtD
Labetalol—Bronchospasm—Bleomycin—skin cancer	0.00499	0.00503	CcSEcCtD
Labetalol—Oropharyngeal pain—Docetaxel—skin cancer	0.00499	0.00503	CcSEcCtD
Labetalol—Erythema—Imiquimod—skin cancer	0.00498	0.00501	CcSEcCtD
Labetalol—Vomiting—Vismodegib—skin cancer	0.0049	0.00494	CcSEcCtD
Labetalol—Affect lability—Temozolomide—skin cancer	0.00487	0.00491	CcSEcCtD
Labetalol—Rash—Vismodegib—skin cancer	0.00486	0.0049	CcSEcCtD
Labetalol—Amnesia—Fluorouracil—skin cancer	0.00486	0.00489	CcSEcCtD
Labetalol—Dermatitis—Vismodegib—skin cancer	0.00486	0.00489	CcSEcCtD
Labetalol—Anaphylactic shock—Vemurafenib—skin cancer	0.00476	0.0048	CcSEcCtD
Labetalol—Mood swings—Temozolomide—skin cancer	0.00469	0.00473	CcSEcCtD
Labetalol—Cardiac failure—Fluorouracil—skin cancer	0.00468	0.00471	CcSEcCtD
Labetalol—Lethargy—Fluorouracil—skin cancer	0.00466	0.00469	CcSEcCtD
Labetalol—Ill-defined disorder—Imiquimod—skin cancer	0.00462	0.00465	CcSEcCtD
Labetalol—Nausea—Vismodegib—skin cancer	0.00458	0.00461	CcSEcCtD
Labetalol—Angioedema—Imiquimod—skin cancer	0.00455	0.00458	CcSEcCtD
Labetalol—Malaise—Imiquimod—skin cancer	0.00449	0.00452	CcSEcCtD
Labetalol—Syncope—Imiquimod—skin cancer	0.00446	0.0045	CcSEcCtD
Labetalol—Hypotension—Vemurafenib—skin cancer	0.00445	0.00448	CcSEcCtD
Labetalol—Palpitations—Imiquimod—skin cancer	0.0044	0.00443	CcSEcCtD
Labetalol—Loss of consciousness—Imiquimod—skin cancer	0.00437	0.00441	CcSEcCtD
Labetalol—Hypertension—Imiquimod—skin cancer	0.0043	0.00433	CcSEcCtD
Labetalol—Discomfort—Imiquimod—skin cancer	0.00419	0.00422	CcSEcCtD
Labetalol—Sweating increased—Temozolomide—skin cancer	0.00417	0.0042	CcSEcCtD
Labetalol—Fatigue—Vemurafenib—skin cancer	0.00411	0.00414	CcSEcCtD
Labetalol—Constipation—Vemurafenib—skin cancer	0.00407	0.0041	CcSEcCtD
Labetalol—Oedema—Imiquimod—skin cancer	0.00406	0.00409	CcSEcCtD
Labetalol—Hypoaesthesia—Bleomycin—skin cancer	0.00404	0.00407	CcSEcCtD
Labetalol—Dysuria—Temozolomide—skin cancer	0.004	0.00403	CcSEcCtD
Labetalol—Shock—Imiquimod—skin cancer	0.004	0.00403	CcSEcCtD
Labetalol—Erectile dysfunction—Temozolomide—skin cancer	0.00394	0.00397	CcSEcCtD
Labetalol—Agranulocytosis—Dactinomycin—skin cancer	0.00394	0.00397	CcSEcCtD
Labetalol—Hyperhidrosis—Imiquimod—skin cancer	0.00393	0.00396	CcSEcCtD
Labetalol—Angina pectoris—Fluorouracil—skin cancer	0.00384	0.00387	CcSEcCtD
Labetalol—Depression—Temozolomide—skin cancer	0.00381	0.00383	CcSEcCtD
Labetalol—Hepatitis—Dactinomycin—skin cancer	0.00379	0.00382	CcSEcCtD
Labetalol—Flushing—Bleomycin—skin cancer	0.00377	0.0038	CcSEcCtD
Labetalol—Body temperature increased—Vemurafenib—skin cancer	0.00376	0.00379	CcSEcCtD
Labetalol—Paraesthesia—Imiquimod—skin cancer	0.00365	0.00367	CcSEcCtD
Labetalol—Dyspnoea—Imiquimod—skin cancer	0.00362	0.00365	CcSEcCtD
Labetalol—Somnolence—Imiquimod—skin cancer	0.00361	0.00364	CcSEcCtD
Labetalol—Alopecia—Bleomycin—skin cancer	0.00359	0.00362	CcSEcCtD
Labetalol—Dyspepsia—Imiquimod—skin cancer	0.00358	0.0036	CcSEcCtD
Labetalol—Erythema—Bleomycin—skin cancer	0.00354	0.00356	CcSEcCtD
Labetalol—Flushing—Dactinomycin—skin cancer	0.00352	0.00354	CcSEcCtD
Labetalol—Hypersensitivity—Vemurafenib—skin cancer	0.00351	0.00354	CcSEcCtD
Labetalol—Fatigue—Imiquimod—skin cancer	0.0035	0.00353	CcSEcCtD
Labetalol—Pain—Imiquimod—skin cancer	0.00347	0.0035	CcSEcCtD
Labetalol—Hepatitis—Temozolomide—skin cancer	0.00343	0.00345	CcSEcCtD
Labetalol—Asthenia—Vemurafenib—skin cancer	0.00342	0.00344	CcSEcCtD
Labetalol—Hallucination—Temozolomide—skin cancer	0.00341	0.00343	CcSEcCtD
Labetalol—Hypoaesthesia—Temozolomide—skin cancer	0.00341	0.00343	CcSEcCtD
Labetalol—Oedema peripheral—Temozolomide—skin cancer	0.00337	0.0034	CcSEcCtD
Labetalol—Cardiac failure—Docetaxel—skin cancer	0.00337	0.0034	CcSEcCtD
Labetalol—Pruritus—Vemurafenib—skin cancer	0.00337	0.00339	CcSEcCtD
Labetalol—Lethargy—Docetaxel—skin cancer	0.00336	0.00339	CcSEcCtD
Labetalol—Alopecia—Dactinomycin—skin cancer	0.00335	0.00337	CcSEcCtD
Labetalol—Feeling abnormal—Imiquimod—skin cancer	0.00335	0.00337	CcSEcCtD
Labetalol—Gastrointestinal pain—Imiquimod—skin cancer	0.00332	0.00335	CcSEcCtD
Labetalol—Epistaxis—Fluorouracil—skin cancer	0.00332	0.00334	CcSEcCtD
Labetalol—Visual impairment—Temozolomide—skin cancer	0.0033	0.00333	CcSEcCtD
Labetalol—Erythema—Dactinomycin—skin cancer	0.0033	0.00332	CcSEcCtD
Labetalol—Agranulocytosis—Fluorouracil—skin cancer	0.00328	0.00331	CcSEcCtD
Labetalol—Ill-defined disorder—Bleomycin—skin cancer	0.00328	0.00331	CcSEcCtD
Labetalol—Diarrhoea—Vemurafenib—skin cancer	0.00326	0.00328	CcSEcCtD
Labetalol—Urticaria—Imiquimod—skin cancer	0.00323	0.00325	CcSEcCtD
Labetalol—Body temperature increased—Imiquimod—skin cancer	0.00321	0.00324	CcSEcCtD
Labetalol—Abdominal pain—Imiquimod—skin cancer	0.00321	0.00324	CcSEcCtD
Labetalol—Malaise—Bleomycin—skin cancer	0.00319	0.00321	CcSEcCtD
Labetalol—Flushing—Temozolomide—skin cancer	0.00318	0.0032	CcSEcCtD
Labetalol—Dizziness—Vemurafenib—skin cancer	0.00315	0.00317	CcSEcCtD
Labetalol—Hypoaesthesia—Fluorouracil—skin cancer	0.00314	0.00316	CcSEcCtD
Labetalol—Ill-defined disorder—Dactinomycin—skin cancer	0.00306	0.00308	CcSEcCtD
Labetalol—Liver function test abnormal—Docetaxel—skin cancer	0.00304	0.00306	CcSEcCtD
Labetalol—Vomiting—Vemurafenib—skin cancer	0.00303	0.00305	CcSEcCtD
Labetalol—Alopecia—Temozolomide—skin cancer	0.00303	0.00305	CcSEcCtD
Labetalol—Abdominal pain upper—Docetaxel—skin cancer	0.00301	0.00303	CcSEcCtD
Labetalol—Orthostatic hypotension—Docetaxel—skin cancer	0.00301	0.00303	CcSEcCtD
Labetalol—Rash—Vemurafenib—skin cancer	0.003	0.00303	CcSEcCtD
Labetalol—Mental disorder—Temozolomide—skin cancer	0.003	0.00302	CcSEcCtD
Labetalol—Dermatitis—Vemurafenib—skin cancer	0.003	0.00302	CcSEcCtD
Labetalol—Hypersensitivity—Imiquimod—skin cancer	0.00299	0.00302	CcSEcCtD
Labetalol—Headache—Vemurafenib—skin cancer	0.00298	0.00301	CcSEcCtD
Labetalol—Erythema—Temozolomide—skin cancer	0.00298	0.003	CcSEcCtD
Labetalol—Discomfort—Bleomycin—skin cancer	0.00297	0.003	CcSEcCtD
Labetalol—Malaise—Dactinomycin—skin cancer	0.00297	0.003	CcSEcCtD
Labetalol—Cramp muscle—Docetaxel—skin cancer	0.00297	0.00299	CcSEcCtD
Labetalol—Asthenia—Imiquimod—skin cancer	0.00291	0.00294	CcSEcCtD
Labetalol—Confusional state—Bleomycin—skin cancer	0.00291	0.00293	CcSEcCtD
Labetalol—Anaphylactic shock—Bleomycin—skin cancer	0.00289	0.00291	CcSEcCtD
Labetalol—Oedema—Bleomycin—skin cancer	0.00289	0.00291	CcSEcCtD
Labetalol—Pruritus—Imiquimod—skin cancer	0.00287	0.0029	CcSEcCtD
Labetalol—Nausea—Vemurafenib—skin cancer	0.00283	0.00285	CcSEcCtD
Labetalol—Vision blurred—Temozolomide—skin cancer	0.00281	0.00283	CcSEcCtD
Labetalol—Bronchospasm—Docetaxel—skin cancer	0.0028	0.00282	CcSEcCtD
Labetalol—Tremor—Temozolomide—skin cancer	0.00279	0.00282	CcSEcCtD
Labetalol—Alopecia—Fluorouracil—skin cancer	0.00279	0.00281	CcSEcCtD
Labetalol—Diarrhoea—Imiquimod—skin cancer	0.00278	0.0028	CcSEcCtD
Labetalol—Discomfort—Dactinomycin—skin cancer	0.00277	0.00279	CcSEcCtD
Labetalol—Angina pectoris—Docetaxel—skin cancer	0.00277	0.00279	CcSEcCtD
Labetalol—Ill-defined disorder—Temozolomide—skin cancer	0.00277	0.00279	CcSEcCtD
Labetalol—Erythema—Fluorouracil—skin cancer	0.00275	0.00277	CcSEcCtD
Labetalol—Angioedema—Temozolomide—skin cancer	0.00272	0.00275	CcSEcCtD
Labetalol—Hypotension—Bleomycin—skin cancer	0.0027	0.00272	CcSEcCtD
Labetalol—Oedema—Dactinomycin—skin cancer	0.00269	0.00271	CcSEcCtD
Labetalol—Malaise—Temozolomide—skin cancer	0.00269	0.00271	CcSEcCtD
Labetalol—Dizziness—Imiquimod—skin cancer	0.00269	0.00271	CcSEcCtD
Labetalol—Vertigo—Temozolomide—skin cancer	0.00268	0.0027	CcSEcCtD
Labetalol—Salsalate—PTGS2—skin cancer	0.00265	0.351	CrCbGaD
Labetalol—Palpitations—Temozolomide—skin cancer	0.00264	0.00266	CcSEcCtD
Labetalol—Paraesthesia—Bleomycin—skin cancer	0.00259	0.00261	CcSEcCtD
Labetalol—Vision blurred—Fluorouracil—skin cancer	0.00259	0.00261	CcSEcCtD
Labetalol—Vomiting—Imiquimod—skin cancer	0.00258	0.0026	CcSEcCtD
Labetalol—Hypertension—Temozolomide—skin cancer	0.00257	0.00259	CcSEcCtD
Labetalol—Dyspnoea—Bleomycin—skin cancer	0.00257	0.00259	CcSEcCtD
Labetalol—Rash—Imiquimod—skin cancer	0.00256	0.00258	CcSEcCtD
Labetalol—Dermatitis—Imiquimod—skin cancer	0.00256	0.00258	CcSEcCtD
Labetalol—Headache—Imiquimod—skin cancer	0.00254	0.00256	CcSEcCtD
Labetalol—Discomfort—Temozolomide—skin cancer	0.00251	0.00253	CcSEcCtD
Labetalol—Jaundice—Docetaxel—skin cancer	0.00247	0.00249	CcSEcCtD
Labetalol—Pain—Bleomycin—skin cancer	0.00247	0.00249	CcSEcCtD
Labetalol—Confusional state—Temozolomide—skin cancer	0.00245	0.00247	CcSEcCtD
Labetalol—Oedema—Temozolomide—skin cancer	0.00243	0.00245	CcSEcCtD
Labetalol—Anaphylactic shock—Temozolomide—skin cancer	0.00243	0.00245	CcSEcCtD
Labetalol—Nausea—Imiquimod—skin cancer	0.00241	0.00243	CcSEcCtD
Labetalol—Epistaxis—Docetaxel—skin cancer	0.00239	0.00241	CcSEcCtD
Labetalol—Feeling abnormal—Bleomycin—skin cancer	0.00238	0.0024	CcSEcCtD
Labetalol—Agranulocytosis—Docetaxel—skin cancer	0.00237	0.00239	CcSEcCtD
Labetalol—Hyperhidrosis—Temozolomide—skin cancer	0.00235	0.00237	CcSEcCtD
Labetalol—Fatigue—Dactinomycin—skin cancer	0.00232	0.00234	CcSEcCtD
Labetalol—Discomfort—Fluorouracil—skin cancer	0.00231	0.00233	CcSEcCtD
Labetalol—Pain—Dactinomycin—skin cancer	0.0023	0.00232	CcSEcCtD
Labetalol—Urticaria—Bleomycin—skin cancer	0.00229	0.00231	CcSEcCtD
Labetalol—Body temperature increased—Bleomycin—skin cancer	0.00228	0.0023	CcSEcCtD
Labetalol—Hepatitis—Docetaxel—skin cancer	0.00228	0.0023	CcSEcCtD
Labetalol—Hypoaesthesia—Docetaxel—skin cancer	0.00227	0.00228	CcSEcCtD
Labetalol—Confusional state—Fluorouracil—skin cancer	0.00226	0.00228	CcSEcCtD
Labetalol—Oedema peripheral—Docetaxel—skin cancer	0.00224	0.00226	CcSEcCtD
Labetalol—Oedema—Fluorouracil—skin cancer	0.00224	0.00226	CcSEcCtD
Labetalol—Anaphylactic shock—Fluorouracil—skin cancer	0.00224	0.00226	CcSEcCtD
Labetalol—Feeling abnormal—Dactinomycin—skin cancer	0.00222	0.00223	CcSEcCtD
Labetalol—Gastrointestinal pain—Dactinomycin—skin cancer	0.0022	0.00222	CcSEcCtD
Labetalol—Visual impairment—Docetaxel—skin cancer	0.0022	0.00221	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—skin cancer	0.00219	0.29	CrCbGaD
Labetalol—Paraesthesia—Temozolomide—skin cancer	0.00219	0.0022	CcSEcCtD
Labetalol—Dyspnoea—Temozolomide—skin cancer	0.00217	0.00219	CcSEcCtD
Labetalol—Somnolence—Temozolomide—skin cancer	0.00216	0.00218	CcSEcCtD
Labetalol—Dyspepsia—Temozolomide—skin cancer	0.00214	0.00216	CcSEcCtD
Labetalol—Abdominal pain—Dactinomycin—skin cancer	0.00213	0.00214	CcSEcCtD
Labetalol—Body temperature increased—Dactinomycin—skin cancer	0.00213	0.00214	CcSEcCtD
Labetalol—Hypersensitivity—Bleomycin—skin cancer	0.00213	0.00214	CcSEcCtD
Labetalol—Flushing—Docetaxel—skin cancer	0.00211	0.00213	CcSEcCtD
Labetalol—Fatigue—Temozolomide—skin cancer	0.0021	0.00211	CcSEcCtD
Labetalol—Hypotension—Fluorouracil—skin cancer	0.0021	0.00211	CcSEcCtD
Labetalol—Pain—Temozolomide—skin cancer	0.00208	0.0021	CcSEcCtD
Labetalol—Constipation—Temozolomide—skin cancer	0.00208	0.0021	CcSEcCtD
Labetalol—Asthenia—Bleomycin—skin cancer	0.00207	0.00209	CcSEcCtD
Labetalol—Pruritus—Bleomycin—skin cancer	0.00204	0.00206	CcSEcCtD
Labetalol—Paraesthesia—Fluorouracil—skin cancer	0.00201	0.00203	CcSEcCtD
Labetalol—Alopecia—Docetaxel—skin cancer	0.00201	0.00203	CcSEcCtD
Labetalol—Feeling abnormal—Temozolomide—skin cancer	0.00201	0.00202	CcSEcCtD
Labetalol—Dyspnoea—Fluorouracil—skin cancer	0.002	0.00201	CcSEcCtD
Labetalol—Mental disorder—Docetaxel—skin cancer	0.002	0.00201	CcSEcCtD
Labetalol—Somnolence—Fluorouracil—skin cancer	0.00199	0.00201	CcSEcCtD
Labetalol—Gastrointestinal pain—Temozolomide—skin cancer	0.00199	0.00201	CcSEcCtD
Labetalol—Erythema—Docetaxel—skin cancer	0.00198	0.002	CcSEcCtD
Labetalol—Hypersensitivity—Dactinomycin—skin cancer	0.00198	0.002	CcSEcCtD
Labetalol—Dyspepsia—Fluorouracil—skin cancer	0.00197	0.00199	CcSEcCtD
Labetalol—Urticaria—Temozolomide—skin cancer	0.00193	0.00195	CcSEcCtD
Labetalol—Asthenia—Dactinomycin—skin cancer	0.00193	0.00195	CcSEcCtD
Labetalol—Abdominal pain—Temozolomide—skin cancer	0.00192	0.00194	CcSEcCtD
Labetalol—Body temperature increased—Temozolomide—skin cancer	0.00192	0.00194	CcSEcCtD
Labetalol—Pain—Fluorouracil—skin cancer	0.00192	0.00193	CcSEcCtD
Labetalol—Muscle spasms—Docetaxel—skin cancer	0.00191	0.00192	CcSEcCtD
Labetalol—Feeling abnormal—Fluorouracil—skin cancer	0.00185	0.00186	CcSEcCtD
Labetalol—Diarrhoea—Dactinomycin—skin cancer	0.00184	0.00186	CcSEcCtD
Labetalol—Vomiting—Bleomycin—skin cancer	0.00183	0.00185	CcSEcCtD
Labetalol—Rash—Bleomycin—skin cancer	0.00182	0.00183	CcSEcCtD
Labetalol—Dermatitis—Bleomycin—skin cancer	0.00182	0.00183	CcSEcCtD
Labetalol—Hypersensitivity—Temozolomide—skin cancer	0.00179	0.00181	CcSEcCtD
Labetalol—Urticaria—Fluorouracil—skin cancer	0.00178	0.0018	CcSEcCtD
Labetalol—Syncope—Docetaxel—skin cancer	0.00178	0.00179	CcSEcCtD
Labetalol—Body temperature increased—Fluorouracil—skin cancer	0.00177	0.00179	CcSEcCtD
Labetalol—Palpitations—Docetaxel—skin cancer	0.00175	0.00177	CcSEcCtD
Labetalol—Asthenia—Temozolomide—skin cancer	0.00175	0.00176	CcSEcCtD
Labetalol—Loss of consciousness—Docetaxel—skin cancer	0.00174	0.00176	CcSEcCtD
Labetalol—Pruritus—Temozolomide—skin cancer	0.00172	0.00174	CcSEcCtD
Labetalol—Nausea—Bleomycin—skin cancer	0.00171	0.00173	CcSEcCtD
Labetalol—Hypertension—Docetaxel—skin cancer	0.00171	0.00173	CcSEcCtD
Labetalol—Vomiting—Dactinomycin—skin cancer	0.00171	0.00172	CcSEcCtD
Labetalol—Rash—Dactinomycin—skin cancer	0.0017	0.00171	CcSEcCtD
Labetalol—Diarrhoea—Temozolomide—skin cancer	0.00167	0.00168	CcSEcCtD
Labetalol—Hypersensitivity—Fluorouracil—skin cancer	0.00165	0.00166	CcSEcCtD
Labetalol—Confusional state—Docetaxel—skin cancer	0.00163	0.00164	CcSEcCtD
Labetalol—Anaphylactic shock—Docetaxel—skin cancer	0.00162	0.00163	CcSEcCtD
Labetalol—Oedema—Docetaxel—skin cancer	0.00162	0.00163	CcSEcCtD
Labetalol—Dizziness—Temozolomide—skin cancer	0.00161	0.00162	CcSEcCtD
Labetalol—Nausea—Dactinomycin—skin cancer	0.0016	0.00161	CcSEcCtD
Labetalol—Shock—Docetaxel—skin cancer	0.00159	0.0016	CcSEcCtD
Labetalol—Pruritus—Fluorouracil—skin cancer	0.00159	0.0016	CcSEcCtD
Labetalol—Vomiting—Temozolomide—skin cancer	0.00155	0.00156	CcSEcCtD
Labetalol—Rash—Temozolomide—skin cancer	0.00153	0.00155	CcSEcCtD
Labetalol—Diarrhoea—Fluorouracil—skin cancer	0.00153	0.00155	CcSEcCtD
Labetalol—Dermatitis—Temozolomide—skin cancer	0.00153	0.00154	CcSEcCtD
Labetalol—Headache—Temozolomide—skin cancer	0.00152	0.00154	CcSEcCtD
Labetalol—Hypotension—Docetaxel—skin cancer	0.00151	0.00152	CcSEcCtD
Labetalol—Dizziness—Fluorouracil—skin cancer	0.00148	0.00149	CcSEcCtD
Labetalol—Paraesthesia—Docetaxel—skin cancer	0.00145	0.00146	CcSEcCtD
Labetalol—Nausea—Temozolomide—skin cancer	0.00145	0.00146	CcSEcCtD
Labetalol—Dyspnoea—Docetaxel—skin cancer	0.00144	0.00145	CcSEcCtD
Labetalol—Somnolence—Docetaxel—skin cancer	0.00144	0.00145	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—skin cancer	0.00143	0.189	CrCbGaD
Labetalol—Vomiting—Fluorouracil—skin cancer	0.00143	0.00144	CcSEcCtD
Labetalol—Dyspepsia—Docetaxel—skin cancer	0.00142	0.00144	CcSEcCtD
Labetalol—Rash—Fluorouracil—skin cancer	0.00141	0.00142	CcSEcCtD
Labetalol—Dermatitis—Fluorouracil—skin cancer	0.00141	0.00142	CcSEcCtD
Labetalol—Headache—Fluorouracil—skin cancer	0.0014	0.00142	CcSEcCtD
Labetalol—Fatigue—Docetaxel—skin cancer	0.0014	0.00141	CcSEcCtD
Labetalol—Pain—Docetaxel—skin cancer	0.00138	0.00139	CcSEcCtD
Labetalol—Constipation—Docetaxel—skin cancer	0.00138	0.00139	CcSEcCtD
Labetalol—Feeling abnormal—Docetaxel—skin cancer	0.00133	0.00134	CcSEcCtD
Labetalol—Nausea—Fluorouracil—skin cancer	0.00133	0.00134	CcSEcCtD
Labetalol—Gastrointestinal pain—Docetaxel—skin cancer	0.00132	0.00133	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—skin cancer	0.00129	0.171	CrCbGaD
Labetalol—Body temperature increased—Docetaxel—skin cancer	0.00128	0.00129	CcSEcCtD
Labetalol—Abdominal pain—Docetaxel—skin cancer	0.00128	0.00129	CcSEcCtD
Labetalol—Hypersensitivity—Docetaxel—skin cancer	0.00119	0.0012	CcSEcCtD
Labetalol—Asthenia—Docetaxel—skin cancer	0.00116	0.00117	CcSEcCtD
Labetalol—Pruritus—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Labetalol—Diarrhoea—Docetaxel—skin cancer	0.00111	0.00112	CcSEcCtD
Labetalol—Dizziness—Docetaxel—skin cancer	0.00107	0.00108	CcSEcCtD
Labetalol—Vomiting—Docetaxel—skin cancer	0.00103	0.00104	CcSEcCtD
Labetalol—Rash—Docetaxel—skin cancer	0.00102	0.00103	CcSEcCtD
Labetalol—Dermatitis—Docetaxel—skin cancer	0.00102	0.00103	CcSEcCtD
Labetalol—Headache—Docetaxel—skin cancer	0.00101	0.00102	CcSEcCtD
Labetalol—Nausea—Docetaxel—skin cancer	0.000961	0.000969	CcSEcCtD
